4.4 Article

Copy-number variation associated with congenital anomalies of the kidney and urinary tract

Journal

PEDIATRIC NEPHROLOGY
Volume 30, Issue 3, Pages 487-495

Publisher

SPRINGER
DOI: 10.1007/s00467-014-2962-9

Keywords

Congenital anomalies of the kidney and urinary tract; CAKUT; Copy-number variation; Posterior urethral valves; Kidney development; Ureter development

Funding

  1. National Health and Medical Research Council [APP1021532]

Ask authors/readers for more resources

The most common cause of end-stage renal disease in children can be attributed to congenital anomalies of the kidney and urinary tract (CAKUT). Despite this high incidence of disease, the genetic mutations responsible for the majority of CAKUT cases remain unknown. To identify novel genomic regions associated with CAKUT, we screened 178 children presenting with the entire spectrum of structural anomalies associated with CAKUT for submicroscopic chromosomal imbalances (deletions or duplications) using single-nucleotide polymorphism (SNP) microarrays. Copy-number variation (CNV) was detected in 10.1 % (18/178) of the patients; in 6.2 % of the total cohort, novel duplications or deletions of unknown significance were identified, and the remaining 3.9 % harboured CNV of known pathogenicity. CNVs were inherited in 90 % (9/10) of the families tested. In this cohort, patients diagnosed with multicystic dysplastic kidney (30 %) and posterior urethral valves (24 %) had a higher incidence of CNV. The genes contained in the altered genomic regions represent novel candidates for CAKUT. This study has demonstrated that a significant proportion of patients with CAKUT harbour submicroscopic chromosomal imbalances, warranting screening in clinics for CNV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Metaphors and why these are important in all aspects of genetic counseling

Adrienne Sexton, Paul A. James

Summary: Metaphors play a crucial role in communication, learning, and creating meaning, and purposefully working with client-generated and counselor-generated metaphors can enhance the client-counselor relationship in genetic counseling.

JOURNAL OF GENETIC COUNSELING (2022)

Article Genetics & Heredity

Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk

Gillian Gregory, Kuheli Das Gupta, Bettina Meiser, Kristine Barlow-Stewart, Peter Geelan-Small, Rajneesh Kaur, Maatje Scheepers-Joynt, Simone McInerny, Shelby Taylor, Yoland Antill, Lucinda Salmon, Courtney Smyth, Mary-Anne Young, Paul A. James, Tatiane Yanes

Summary: In communicating polygenic risk (PR) for hereditary breast cancer, genetic health professionals tend to use a teaching model rather than a patient-centered approach, which differs from how monogenic risk (MR) is communicated. PR consultations involve significantly less exploration of counselees' reasons for attending genetic counseling or checking their information preferences, decision-making style, medical knowledge, understanding, or concerns compared to MR consultations.

JOURNAL OF GENETIC COUNSELING (2022)

Article Genetics & Heredity

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants

Adam M. Bournazos, Lisa G. Riley, Shobhana Bommireddipalli, Lesley Ades, Lauren S. Akesson, Mohammad Al-Shinnag, Stephen Alexander, Alison D. Archibald, Shanti Balasubramaniam, Yemima Berman, Victoria Beshay, Kirsten Boggs, Jasmina Bojadzieva, Natasha J. Brown, Samantha J. Bryen, Michael F. Buckley, Belinda Chong, Mark R. Davis, Ruebena Dawes, Martin Delatycki, Liz Donaldson, Lilian Downie, Caitlin Edwards, Matthew Edwards, Amanda Engel, Lisa J. Ewans, Fathimath Faiz, Andrew Fennell, Michael Field, Mary-Louise Freckmann, Lyndon Gallacher, Russell Gear, Himanshu Goel, Shuxiang Goh, Linda Goodwin, Bernadette Hanna, James Harraway, Megan Higgins, Gladys Ho, Bruce K. Hopper, Ari E. Horton, Matthew F. Hunter, Aamira J. Huq, Sarah Josephi-Taylor, Himanshu Joshi, Edwin Kirk, Emma Krzesinski, Kishore R. Kumar, Frances Lemckert, Richard J. Leventer, Suzanna E. Lindsey-Temple, Sebastian Lunke, Alan Ma, Steven Macaskill, Amali Mallawaarachchi, Melanie Marty, Justine E. Marum, Hugh J. McCarthy, Manoj P. Menezes, Alison McLean, Di Milnes, Shekeeb Mohammad, David Mowat, Aram Niaz, Elizabeth E. Palmer, Chirag Patel, Shilpan G. Patel, Dean Phelan, Jason R. Pinner, Sulekha Rajagopalan, Matthew Regan, Jonathan Rodgers, Miriam Rodrigues, Richard H. Roxburgh, Rani Sachdev, Tony Roscioli, Ruvishani Samarasekera, Sarah A. Sandaradura, Elena Savva, Tim Schindler, Margit Shah, Ingrid B. Sinnerbrink, Janine M. Smith, Richard J. Smith, Amanda Springer, Zornitza Stark, Samuel P. Strom, Carolyn M. Sue, Kenneth Tan, Tiong Y. Tan, Esther Tantsis, Michel C. Tchan, Bryony A. Thompson, Alison H. Trainer, Karin Van Spaendonck-Zwarts, Rebecca Walsh, Linda Warwick, Stephanie White, Susan M. White, Mark G. Williams, Meredith J. Wilson, Wui Kwan Wong, Dale C. Wright, Patrick Yap, Alison Yeung, Helen Young, Kristi J. Jones, Bruce Bennetts, Sandra T. Cooper

Summary: The study aims to provide standardized practices for PCR-based RNA diagnostics using clinically accessible specimens. The results show that RNA diagnostics can provide meaningful data for most genetic cases, allowing for variant reclassification and important applications in genetic counseling, clinical care, and prenatal counseling.

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Hongyan Li, Christoph Engel, Miguel de la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Luca Livraghi, Paolo Radice, Mads Thomassen, Thomas V. O. Hansen, Anne-Marie Gerdes, Henriette R. Nielsen, Sandrine M. Caputo, Alberto Zambelli, Ake Borg, Angela Solano, Abigail Thomas, Michael T. Parsons, Antonis C. Antoniou, Goska Leslie, Xin Yang, Georgia Chenevix-Trench, Trinidad Caldes, Ava Kwong, Inge Sokilde Pedersen, Charlotte K. Lautrup, Esther M. John, Mary Beth Terry, John L. Hopper, Melissa C. Southey, Irene L. Andrulis, Marc Tischkowitz, Ramunas Janavicius, Susanne E. Boonen, Lone Kroeldrup, Liliana Varesco, Ute Hamann, Ana Vega, Edenir Palmero, Judy Garber, Marco Montagna, Christi J. Van Asperen, Lenka Foretova, Mark H. Greene, Tina Selkirk, Pal Moller, Amanda E. Toland, Susan M. Domchek, Paul A. James, Heather Thorne, Diana M. Eccles, Sarah M. Nielsen, Siranoush Manoukian, Barbara Pasini, Maria A. Caligo, Conxi Lazaro, Judy Kirk, Barbara Wappenschmidt, Amanda B. Spurdle, Fergus J. Couch, Rita Schmutzler, David E. Goldgar

Summary: This study provides important implications for counseling high-risk women with missense pathogenic variants in BRCA1/2 genes, showing that the risks of breast cancer associated with missense variants are significantly lower than those associated with protein truncating variants.

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicity

Cristina Fortuno, Kelly McGoldrick, Tina Pesaran, Jill Dolinsky, Lily Hoang, Jeffrey N. Weitzel, Victoria Beshay, Huei San Leong, Paul A. James, Amanda B. Spurdle

Summary: Studies have shown that variants with low VAF in the TP53 gene may play a role in clonal hematopoiesis. Detection of variants with low VAF can be considered a predictor of TP53 variant pathogenicity, providing diagnostic value.

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

Estimating the proportion of pathogenic variants from breast cancer case-control data: Application to calibration of ACMG/AMP variant classification criteria

Paul A. James, Cristina Fortuno, Na Li, Belle W. X. Lim, Ian G. Campbell, Amanda B. Spurdle

Summary: For genes with reliable estimates of disease risk associated with loss-of-function variants, case-control data can be used to estimate the proportion of variants of typical risk effect. This study derived a calculation for estimating the proportion of pathogenic variants from case-control data and applied it to breast cancer studies, finding evidence of pathogenic variants among rare noncoding variants and variations in the proportion of pathogenic missense variants between genes. The study also revealed the predictive ability of missense variants' location for pathogenicity.

HUMAN MUTATION (2022)

Article Oncology

Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancer

Belle W. X. Lim, Na Li, Simone M. Rowley, Ella R. Thompson, Simone McInerny, Magnus Zethoven, Rodney J. Scott, Lisa Devereux, Erica K. Sloan, Paul A. James, Ian G. Campbell

Summary: The study reveals that rare missense variants in the RAD51C gene are associated with increased familial breast cancer risk and are correlated with specific breast cancer subtypes and mutational characteristics.

NPJ BREAST CANCER (2022)

Article Genetics & Heredity

Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study

Bettina Meiser, Melissa Monnik, Rachel Austin, Cassandra Nichols, Elisa Cops, Lucinda Salmon, Amanda B. Spurdle, Finlay Macrae, Natalie Taylor, Nicholas Pachter, Paul James, Rajneesh Kaur

Summary: The study aimed to describe the acceptability and perceived barriers and enablers to establish a national registry targeting carriers of pathogenic variants in cancer susceptibility genes. Interviews with stakeholders showed enthusiasm and support for the registry, with carriers and healthcare professionals showing positive attitudes towards its potential research applications. Participants had differing opinions regarding consent approaches and data sharing, highlighting the need for careful consideration in developing and managing such a registry.

JOURNAL OF COMMUNITY GENETICS (2022)

Article Cell Biology

The ability of remaining glomerular podocytes to adapt to the loss of their neighbours decreases with age

James van der Wolde, Kotaro Haruhara, Victor G. Puelles, David Nikolic-Paterson, John F. Bertram, Luise A. Cullen-McEwen

Summary: This study investigated the progressive loss of podocytes during healthy aging and how the remaining podocytes respond to podocyte depletion at different ages. The results showed that podocyte number per glomerulus did not change in control mice during the examined time period but control mice at 18 months had the largest podocytes and the lowest podocyte density. Podocyte depletion at different ages resulted in different levels of albuminuria and glomerulosclerosis. In addition, the study found that the mTORC1-mediated podocyte hypertrophy played an important role in both physiological aging and adaptive settings.

CELL AND TISSUE RESEARCH (2022)

Article Genetics & Heredity

Contribution of large genomic rearrangements in PALB2 to familial breast cancer: implications for genetic testing

Na Li, Magnus Zethoven, Simone McInerny, Eliza Healey, Dilanka DeSilva, Lisa Devereux, Rodney J. Scott, Paul A. James, Ian G. Campbell

Summary: PALB2 is the most important contributor to familial breast cancer after BRCA1 and BRCA2. This study shows that a clinically important proportion of PALB2 pathogenic mutations in Australian patients with familial breast cancer are large genomic rearrangements (LGRs).

JOURNAL OF MEDICAL GENETICS (2023)

Article Cardiac & Cardiovascular Systems

Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry

Elizabeth D. Paratz, Alexander van Heusden, Dominica Zentner, Natalie Morgan, Karen Smith, Tina Thompson, Paul James, Vanessa Connell, Andreas Pflaumer, Christopher Semsarian, Jodie Ingles, Sarah Parsons, Dion Stub, Andre La Gerche

Summary: The causes, circumstances, and preventability of young sudden cardiac arrest remain uncertain. This study found that approximately half of young out-of-hospital cardiac arrests (OHCAs) have a cardiac cause, with coronary disease and drug toxicity being the most common etiologies. OHCAs are more likely to occur during sleep, with a disproportionate occurrence during exercise compared to typical Australian days. Interestingly, most patients with a cardiac cause of OHCA had no standard modifiable cardiovascular risk factors and had not reported cardiac symptoms or been evaluated by a cardiologist prior to their OHCA.

EUROPACE (2022)

Article Genetics & Heredity

Psychiatric genetic counseling: A survey of Australian genetic counselors' practice and attitudes

Joanne Isbister, Adrienne Sexton, Laura E. Forrest, Paul James, James Dowty, Jessica Taylor, Jehannine Austin, Ingrid Winship

Summary: Genetic counseling plays a critical role in supporting individuals and their families in adapting to psychiatric conditions. However, little data exists on the practice and attitudes of Australian genetic counselors regarding psychiatric genetic counseling (PGC). This survey found that most Australian genetic counselors do not specialize in psychiatric genetics and rarely see patients with a personal or family history of psychiatric disorders. While more than half of respondents believed there was sufficient evidence to support PGC, only a minority provided genetic counseling on this topic. Most respondents lacked confidence in providing risk assessments for psychiatric disorders but expressed interest in specialist training and incorporating PGC into their future practice.

JOURNAL OF GENETIC COUNSELING (2023)

Article Physiology

Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes

Sarah E. Gazzard, James van Der Wolde, Kotaro Haruhara, John F. Bertram, Luise A. Cullen-McEwen

Summary: This study found that an adverse intrauterine environment, caused by a low protein diet, can lead to reduced podocyte numbers and increased susceptibility to diabetes-induced renal injury. Growth-restricted offspring with low nephron number and normalized podocyte endowment were more susceptible to alterations in glomerular volume and podocyte density, leading to a more rapid onset of albuminuria and renal injury.

PHYSIOLOGICAL REPORTS (2023)

Article Genetics & Heredity

CHEK2 is not a Li-Fraumeni syndrome gene: time to update public resources

Cristina Fortuno, Marcy Richardson, Tina Pesaran, Amal Yussuf, Carolyn Horton, Paul A. James, Amanda B. Spurdle

Summary: Despite published evidence to the contrary, public resources like OMIM and MONDO still list CHEK2 as the gene-disease relationship for 'Li-Fraumeni syndrome 2', causing frustration among LFS clinical experts. The comparison of personal cancer characteristics between 2095 CHEK2 and 248 TP53 pathogenic variant carriers and 15,135 individuals with no known pathogenic variant at Ambry Genetics highlights clear differences in clinical presentation, with no evidence of CHEK2 being associated with any TP53-related LFS cancers. These findings emphasize the need to replace 'Li-Fraumeni syndrome 2' as the disease name associated with CHEK2 to avoid potential confusion.

JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

Daniel R. Barnes, Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis, Xin Yang, Julian Adlard, Bjarni A. Agnarsson, Munaza Ahmed, Kristiina Aittomaki, Irene L. Andrulis, Adalgeir Arason, Norbert Arnold, Bernd Auber, Jacopo Azzollini, Judith Balmana, Rosa B. Barkardottir, Daniel Barrowdale, Julian Barwell, Muriel Belotti, Javier Benitez, Pascaline Berthet, Susanne E. Boonen, Ake Borg, Aniko Bozsik, Angela F. Brady, Paul Brennan, Carole Brewer, Joan Brunet, Agostino Bucalo, Saundra S. Buys, Trinidad Caldes, Maria A. Caligo, Ian Campbell, Hayley Cassingham, Lise Lotte Christensen, Giulia Cini, Kathleen B. M. Claes, Jackie Cook, Anna Coppa, Laura Cortesi, Giuseppe Damante, Esther Darder, Rosemarie Davidson, Miguel de la Hoya, Kim De Leeneer, Robin de Putter, Jesus Del Valle, Orland Diez, Yuan Chun Ding, Susan M. Domchek, Alan Donaldson, Jacqueline Eason, Ros Eeles, Christoph Engel, D. Gareth Evans, Lidia Feliubadalo, Florentia Fostira, Megan Frone, Debra Frost, David Gallagher, Andrea Gehrig, Sophie Giraud, Gord Glendon, Andrew K. Godwin, David E. Goldgar, Mark H. Greene, Helen Gregory, Eva Gross, Eric Hahnen, Ute Hamann, Thomas V. O. Hansen, Helen Hanson, Julia Hentschel, Judit Horvath, Louise Izatt, Angel Izquierdo, Paul A. James, Ramunas Janavicius, Uffe Birk Jensen, Oskar Th Johannsson, Esther M. John, Gero Kramer, Lone Kroeldrup, Torben A. Kruse, Charlotte Lautrup, Conxi Lazaro, Fabienne Lesueur, Adria Lopez-Fernandez, Phuong L. Mai, Siranoush Manoukian, Zoltan Matrai, Laura Matricardi, Kara N. Maxwell, Noura Mebirouk, Alfons Meindl, Marco Montagna, Alvaro N. Monteiro, Patrick J. Morrison, Taru A. Muranen, Alex Murray, Katherine L. Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Tu Nguyen-Dumont, Dieter Niederacher, Edith Olah, Olufunmilayo Olopade, Domenico Palli, Michael T. Parsons, Inge Sokilde Pedersen, Bernard Peissel, Pedro Perez-Segura, Paolo Peterlongo, Annabeth H. Petersen, Pedro Pinto, Mary E. Porteous, Caroline Pottinger, Miquel Angel Pujana, Paolo Radice, Juliane Ramser, Johanna Rantala, Mark Robson, Mark T. Rogers, Karina Ronlund, Andreas Rump, Ana Maria Sanchez de Abajo, Payal D. Shah, Saba Sharif, Lucy E. Side, Christian F. Singer, Zsofia Stadler, Linda Steele, Dominique Stoppa-Lyonnet, Christian Sutter, Yen Yen Tan, Manuel R. Teixeira, Alex Teule, Darcy L. Thull, Marc Tischkowitz, Amanda E. Toland, Stefania Tommasi, Angela Toss, Alison H. Trainer, Vishakha Tripathi, Virginia Valentini, Christi J. van Asperen, Marta Venturelli, Alessandra Viel, Joseph Vijai, Lisa Walker, Shan Wang-Gohrke, Barbara Wappenschmidt, Anna Whaite, Ines Zanna, Kenneth Offit, Mads Thomassen, Fergus J. Couch, Rita K. Schmutzler, Jacques Simard, Douglas F. Easton, Georgia Chenevix-Trench, Antonis C. Antoniou, Laura Ottini

Summary: The study assessed the associations of polygenic risk scores with breast and prostate cancer risks for male BRCA1 and BRCA2 carriers, finding strong associations between the risk scores and the respective cancer risks. The estimated breast cancer odds ratios were larger after adjusting for family history of female relative breast cancer.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

No Data Available